A new paper in the Journal of Translational Medicine (Gile, Roy et al., 2026) is one of the most mechanistically detailed pieces of evidence yet for a treatment I’ve been building into the pharmacolog...

Findings from RECOVER’s pediatric observational study show that Long COVID can affect children’s health and daily lives in different ways. During the September 15, 2026, RECOVER Research Review (R3) S...

Changes in guidance and science seem to have little impact on millions of devastated lives. It’s a social crisis playing out behind closed doors, says Guardian columnist George Monbiot

Donate to support individuals and families harmed by ICE activities in greater New Bedford.

Governor Maura Healey said many of the detained individuals have lived in Massachusetts for “many years” and were on their way to work when they were taken into custody.

Join the De-ICE Action Network–which is evolving from the De-ICE Citizens Bank campaign– to send a message to Boston Dynamics to not trust ICE with their Spot Robot Dogs. Organizers will have flyer...

Joan Esposito is joined by Dr. Judy Stone, infectious diseases physician, journalist and author. Last month she wrote a piece for Forbes called "Covid-19 Cases Surge—Here’s What’s Different This Summe...

This JAMA Pediatrics Patient Page describes the symptoms of long COVID in children.

The long-term effects of COVID are real. Join the NIH in the search for answers.

With the new presidential administration beginning mass deportations, this is a frightening time for many immigrants and their families.…

More than 40 officials and board members across UnitedHealth cumulatively donated more than $100,000 to Clark’s campaign during the 2025-2026 election cycle.

This technical report accompanies the American Academy of Pediatrics policy statement recommendations for COVID-19 vaccination during the 2026–2027 respiratory virus season. The rationale is presented for recommending vaccination in all infants and children 6 through 23 months of age, children 6 months through 18 years of age who are moderately or severely immunocompromised, and children 2 through 18 years of age in certain additional risk groups, including those at high risk of severe COVID-19, residents of long-term care facilities or other congregate settings, children who have never been vaccinated against COVID-19, and children whose household contacts are at high risk for severe COVID-19. The report synthesizes currently available evidence on SARS-CoV-2 epidemiology, disease burden, COVID-19 vaccine effectiveness, vaccine safety, and vaccine cost-effectiveness in pediatric populations. Additionally, the report provides an overview of available COVID-19 vaccine products, formulations, storage and handling considerations, and coadministration with other immunizations.